Clot formation and fibrinolysis assays reveal functional differences among hemostatic agents in hemophilia A plasma

CONCLUSION: Clotting and fibrinolysis assays reveal hemostatic effects of replacement and bypassing therapies at clinically relevant concentrations. These assays may help characterize hemostatic agents and optimize dosing.PMID:38426025 | PMC:PMC10901841 | DOI:10.1016/j.rpth.2024.102337

Source: Thrombosis and Haemostasis - March 1, 2024 Category: Hematology Authors: Lori A Holle Jacob C Pantazis Peter L Turecek Alisa S Wolberg Source Type: research